Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Pharmacology & Therapeutics
|
July 17, 2012
The application and biology of immunomodulatory drugs (IMiDs) in cancer
Beiqing Pan, Suzanne Lentzsch
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2012
Brentuximab vedotin
Changchun Deng, Beiqing Pan, Owen A O'Connor
Anticancer Research
|
April 12, 2012
Secondary tumors of the pancreas: a case series
Beiqing Pan, Yoomi Lee, Teresa Rodriguez, et al.
Protein & Cell
|
November 22, 2019
USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer
Beiqing Pan, Yi Yang, Jian Li, et al.
Bone
|
August 24, 2006
Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patients
Helen Tsangari, David M Findlay, Andrew C W Zannettino, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 3, 2004
The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE)
Beiqing Pan, Amanda N Farrugia, Luen Bik To, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 24, 2003
RANKL expression is related to the differentiation state of human osteoblasts
Gerald J Atkins, Panagiota Kostakis, Beiqing Pan, et al.
Cell Research
|
July 20, 2019
Structural insights into the activation of ATM kinase
Jianxiong Xiao, Mengjie Liu, Yilun Qi, et al.
Cancer Research
|
September 23, 2003
Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo
Amanda N Farrugia, Gerald J Atkins, L Bik To, et al.
Bone
|
January 31, 2004
The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro
Beiqing Pan, Luen Bik To, Amanda N Farrugia, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Pharmacology & Therapeutics
|
July 17, 2012
The application and biology of immunomodulatory drugs (IMiDs) in cancer
Beiqing Pan, Suzanne Lentzsch
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2012
Brentuximab vedotin
Changchun Deng, Beiqing Pan, Owen A O'Connor
Anticancer Research
|
April 12, 2012
Secondary tumors of the pancreas: a case series
Beiqing Pan, Yoomi Lee, Teresa Rodriguez, et al.
Protein & Cell
|
November 22, 2019
USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer
Beiqing Pan, Yi Yang, Jian Li, et al.
Bone
|
August 24, 2006
Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patients
Helen Tsangari, David M Findlay, Andrew C W Zannettino, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 3, 2004
The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE)
Beiqing Pan, Amanda N Farrugia, Luen Bik To, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 24, 2003
RANKL expression is related to the differentiation state of human osteoblasts
Gerald J Atkins, Panagiota Kostakis, Beiqing Pan, et al.
Cell Research
|
July 20, 2019
Structural insights into the activation of ATM kinase
Jianxiong Xiao, Mengjie Liu, Yilun Qi, et al.
Cancer Research
|
September 23, 2003
Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo
Amanda N Farrugia, Gerald J Atkins, L Bik To, et al.
Bone
|
January 31, 2004
The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro
Beiqing Pan, Luen Bik To, Amanda N Farrugia, et al.
Page
of 1